InnoCare Pharma Ltd
InnoCare Pharma's GHG Emissions Data Preview
In 2023, InnoCare Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, InnoCare Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data. a | 0000000 |
Verified Sources Behind InnoCare Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore InnoCare Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into InnoCare Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of InnoCare Pharma amounted to 12,134.54 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of InnoCare Pharma increased by 23.37%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
InnoCare Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are InnoCare Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of InnoCare Pharma were 19.95 metric tons of CO₂ equivalent (tCO₂e). a
What are InnoCare Pharma's Scope 2 emissions?
In 2023, InnoCare Pharma reported Scope 2 greenhouse gas (GHG) emissions of 12,114.59 tCO₂e without specifying the calculation method. a
Has InnoCare Pharma reduced its Scope 2 emissions over time?
Since 2020, InnoCare Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 389.16%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), InnoCare Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 23.17% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does InnoCare Pharma use for Scope 2 reporting?
In 2023, InnoCare Pharma reported its Scope 2 emissions using an unspecified methodology. a
InnoCare Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into InnoCare Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2023, InnoCare Pharma reported Scope 1 greenhouse gas (GHG) emissions of 19.95 tCO₂e and total revenues of USD 104 millions. This translates into an emissions intensity of 0.19 tCO₂e per millions USD. a
InnoCare Pharma's Scope 1 Emissions Intensity Compared to Peers
How does InnoCare Pharma's GHG emissions intensity compare to its peers?
In 2023, InnoCare Pharma reported a Scope 1 emissions intensity of 0.19 tCO₂e per millions USD. Compared to the peer group median of 9.12 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does InnoCare Pharma rank on GHG emissions intensity within its industry?
In 2023, InnoCare Pharma ranked 4 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places InnoCare Pharma among the top performers, with one of the lowest emissions intensities relative to peers. a